Inventor · disambiguated record
Iram Khan
Also filed as: KHAN IRAM · KHAN IRAM F · KHAN IRAM FATIMA
3 granted patents·9 pending applications·2 citations·filing 2018–2024
53Inventor score
Files withSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST5SEATTLE CHILDRENS HOSPITAL3SEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE2CSL BEHRING L L C1SEATTIE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE1
Top patents by PatentIndex Score
12 records- 0177US11713459B2Expression of FOXP3 in edited CD34+ cellsSEATTLE CHILDRENS HOSPITAL·Filed 2019·Granted Aug 1, 2023·2 cites·10 claims
- 0266US2024141389A1Therapeutic genome editing in wiskott-aldrich syndrome and x-linked thrombocytopeniaSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2023·Application pending·0 cites
- 0364US2024117352A1Expression of foxp3 in edited cd34+ cellsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2023·Application pending·0 cites
- 0463US2024287452A1Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteinsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2024·Application pending·0 cites
- 0559US11643671B2Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked thrombocytopeniaSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted May 9, 2023·0 cites·17 claims
- 0656US2025354166A1Lentiviral vectors useful for the treatment of diseaseCSL BEHRING L L C·Filed 2022·Application pending·0 cites
- 0753US11939594B2Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteinsSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted Mar 26, 2024·0 cites·15 claims
- 0849US2022364123A1Wiskott-aldrich syndrome gene homing endonuclease variants, compositions, and methods of useSEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE·Filed 2020·Application pending·0 cites
- 0945US2021230565A1Bruton's tyrosine kinase homing endonuclease variants, compositions, and methods of useSEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE·Filed 2019·Application pending·0 cites
- 1044US2022064651A1Talen-based and crispr/cas-based gene editing for bruton's tyrosine kinaseSEATTIE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE·Filed 2019·Application pending·0 cites
- 1141US2021324381A1Therapeutic genome editing in x-linked hyper igm syndromeSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2019·Application pending·0 cites
- 1234US2021253652A1Expression of human foxp3 in gene edited t cellsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →